|
AD Connect
  • User
  • Home
  • Tech Help
  • AD Discovery Portal
  • FDSA
  • Discussions
  • Datasets
  • Video Library
Datasets
Datasets

Forums

  • Datasets
  • Forums
  • Tags
  • More
  • Cancel
  • New
  • A blood based 12-miRNA signature of Alzheimer patients - GSE46579

    A forum to discuss or ask questions about a blood based 12-miRNA signature of Alzheimer patients - GSE46579.
    1 question or discussion
    Sebastian Ford
    ADDI's editorial take over 2 years ago
  • A double-blind, randomised, placebo-controlled, parallel-group dose-ranging study

    A forum to discuss or ask questions about a double-blind, randomised, placebo-controlled, parallel-group dose-ranging study
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • A Phase 2a Study

    A forum to discuss or ask questions about a Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • A Randomised, Double-blind, Placebo-controlled Study

    A forum to discuss or ask questions about a Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the H3 Receptor Antagonist, GSK239512 in Subjects with Mild to Moderate Alzheimer's Disease.
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • A Randomised, Single-Blind, Placebo-Controlled Study

    A forum to discuss or ask questions about a Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients with Alzheimer
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • A reference induced pluripotent stem cell line for large-scale collaborative studies

    A forum to discuss or ask questions about a reference induced pluripotent stem cell line for large-scale collaborative studies
    4 questions and discussions
    Klaus Lehnert
    Access to KOLF2.1J WGS FASTQ and VCF files 2 months ago
  • A Single Blind, Placebo-controlled, Randomised Study

    A forum to discuss or ask questions about a Single Blind, Placebo-controlled, Randomised Study in Mild to Moderate Alzheimer's Disease Patients to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK239512, a Selective Histamin
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • A Study of Semagacestat for Alzheimer's Patients

    A forum to discuss or ask questions about the Study of Semagacestat for Alzheimer's Patients.
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • AD Synthetic Patient Data

    A forum to discuss or ask questions about the AD Synthetic Patient Data.
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • AMYPAD Prognostic and Natural History Study (PNHS)

    3 questions and discussions
    Emma Luckett
    Recent AMYPAD PNHS dataset questions over 1 year ago
  • An Open Label Single Oral Dose Study

    A forum to discuss or ask questions about an Open Label Single Oral Dose Study in Patients with Mild Alzheimer's Disease to Assess the Pharmacokinetics of Extended-Release Formulation of Rosiglitazone (RSG XR) in This Population
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • An Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

    A forum to discuss or ask questions about an Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
    0 questions and discussions
  • An open-label extension to study AVA100193

    A forum to discuss or ask questions about an open-label extension to study AVA100193
    0 questions
  • An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended-release tablets) in subjects with mild to moderate Alzheimer's disease

    A forum to discuss or ask questions about an open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended-release tablets) in subjects with mild to moderate Alzheimer's disease
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • An Open-label Extension to Study AVA102670 and AVA102672

    A forum to discuss or ask questions about an Open-label Extension to Study AVA102670 and AVA102672, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended-Release Tablets) as Adjunctive Therapy on Cognition in Subjects with Mild to Moderate
    1 question or discussion
    Caitlin McHugh (moderator)
    RE: ADDI's Editorial Take over 2 years ago
  • An Open-label Extension to Study AVA105640

    A forum to discuss or ask questions about an Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended-Release Tablets) on Cognition in Subjects with Mild to Moderate Alzheimer's Disease.
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
  • Banner Alzheimer's Prevention Initiative

    A forum to discuss or ask questions about the Banner API Generation 1 and 2 studies.
    0 questions and discussions
  • BLSA Open Data

    A forum to discuss or ask questions about BLSA Open Data.
    0 questions
  • BLSA Synthetic Data

    A forum to discuss or ask questions about BLSA Synthetic Data.
    0 questions
  • Brain Imaging Study of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

    A forum to discuss or ask questions about the brain Imaging Study of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
    1 question or discussion
    Sebastian Ford
    ADDI's Editorial Take over 2 years ago
>